Industry: Medical Devices & Consumables
Published Date: 2024-01-10
Pages: 100 Pages
Report ld: 3016188
Request Sample
Customized Report
Cell Saver Market Size(US$)

CAGR 2024-2030
3.5%
Market Size,2030
USD 319.6
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.
The global market for Cell Saver was estimated to be worth US$ 251 million in 2023 and is forecast to a readjusted size of US$ 319.6 million by 2030 with a CAGR of 3.5% during the forecast period 2024-2030
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. A blood salvage machine, also known as an autologous transfusion salvage system or an autologous blood transfusion machine, is a medical device used to salvage and process a patient's own blood during surgery before returning it to the patient. Such a system could be used to reduce the need for exogenous blood transfusions during surgery, thereby reducing the risks and complications associated with blood transfusions for patients. The blood salvage machine works by collecting the blood produced in the patient's body through a specialized system, processing it to remove impurities and platelet aggregation, and then returning the processed blood to the patient. This method is actually a form of autologous blood transfusion, because the blood returned comes from the patient itself, and there is no compatibility problem between the donor and the recipient.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Cell Saver, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cell Saver by region & country, by Type, and by Application.
The Cell Saver market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Saver.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cell Saver manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Cell Saver in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Cell Saver in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Cell Saver Product Introduction
1.2 Global Cell Saver Market Size Forecast
1.2.1 Global Cell Saver Sales Value (2019-2030)
1.2.2 Global Cell Saver Sales Volume (2019-2030)
1.2.3 Global Cell Saver Sales Price (2019-2030)
1.3 Cell Saver Market Trends & Drivers
1.3.1 Cell Saver Industry Trends
1.3.2 Cell Saver Market Drivers & Opportunity
1.3.3 Cell Saver Market Challenges
1.3.4 Cell Saver Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cell Saver Players Revenue Ranking (2023)
2.2 Global Cell Saver Revenue by Company (2019-2024)
2.3 Global Cell Saver Players Sales Volume Ranking (2023)
2.4 Global Cell Saver Sales Volume by Company Players (2019-2024)
2.5 Global Cell Saver Average Price by Company (2019-2024)
2.6 Key Manufacturers Cell Saver Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Cell Saver Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Cell Saver
2.9 Cell Saver Market Competitive Analysis
2.9.1 Cell Saver Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Cell Saver Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Saver as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Intraoperative Autotransfusion Systems
3.1.2 Postoperative Autotransfusion Systems
3.1.3 Dual-Mode Autotransfusion Systems
3.2 Global Cell Saver Sales Value by Type
3.2.1 Global Cell Saver Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cell Saver Sales Value, by Type (2019-2030)
3.2.3 Global Cell Saver Sales Value, by Type (%) (2019-2030)
3.3 Global Cell Saver Sales Volume by Type
3.3.1 Global Cell Saver Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Cell Saver Sales Volume, by Type (2019-2030)
3.3.3 Global Cell Saver Sales Volume, by Type (%) (2019-2030)
3.4 Global Cell Saver Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cardiac Surgeries
4.1.2 Orthopedic Surgeries
4.1.3 Organ Transplantation
4.1.4 Others
4.2 Global Cell Saver Sales Value by Application
4.2.1 Global Cell Saver Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cell Saver Sales Value, by Application (2019-2030)
4.2.3 Global Cell Saver Sales Value, by Application (%) (2019-2030)
4.3 Global Cell Saver Sales Volume by Application
4.3.1 Global Cell Saver Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Cell Saver Sales Volume, by Application (2019-2030)
4.3.3 Global Cell Saver Sales Volume, by Application (%) (2019-2030)
4.4 Global Cell Saver Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Cell Saver Sales Value by Region
5.1.1 Global Cell Saver Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cell Saver Sales Value by Region (2019-2024)
5.1.3 Global Cell Saver Sales Value by Region (2025-2030)
5.1.4 Global Cell Saver Sales Value by Region (%), (2019-2030)
5.2 Global Cell Saver Sales Volume by Region
5.2.1 Global Cell Saver Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Cell Saver Sales Volume by Region (2019-2024)
5.2.3 Global Cell Saver Sales Volume by Region (2025-2030)
5.2.4 Global Cell Saver Sales Volume by Region (%), (2019-2030)
5.3 Global Cell Saver Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Cell Saver Sales Value, 2019-2030
5.4.2 North America Cell Saver Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Cell Saver Sales Value, 2019-2030
5.5.2 Europe Cell Saver Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Cell Saver Sales Value, 2019-2030
5.6.2 Asia Pacific Cell Saver Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Cell Saver Sales Value, 2019-2030
5.7.2 South America Cell Saver Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Cell Saver Sales Value, 2019-2030
5.8.2 Middle East & Africa Cell Saver Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cell Saver Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cell Saver Sales Value
6.2.1 Key Countries/Regions Cell Saver Sales Value, 2019-2030
6.2.2 Key Countries/Regions Cell Saver Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Cell Saver Sales Value, 2019-2030
6.3.2 United States Cell Saver Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cell Saver Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cell Saver Sales Value, 2019-2030
6.4.2 Europe Cell Saver Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cell Saver Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cell Saver Sales Value, 2019-2030
6.5.2 China Cell Saver Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cell Saver Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cell Saver Sales Value, 2019-2030
6.6.2 Japan Cell Saver Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cell Saver Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cell Saver Sales Value, 2019-2030
6.7.2 South Korea Cell Saver Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cell Saver Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cell Saver Sales Value, 2019-2030
6.8.2 Southeast Asia Cell Saver Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cell Saver Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cell Saver Sales Value, 2019-2030
6.9.2 India Cell Saver Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cell Saver Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Haemonetics
7.1.1 Haemonetics Company Information
7.1.2 Haemonetics Introduction and Business Overview
7.1.3 Haemonetics Cell Saver Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Haemonetics Cell Saver Product Offerings
7.1.5 Haemonetics Recent Development
7.2 Medtronic
7.2.1 Medtronic Company Information
7.2.2 Medtronic Introduction and Business Overview
7.2.3 Medtronic Cell Saver Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Medtronic Cell Saver Product Offerings
7.2.5 Medtronic Recent Development
7.3 LivaNova
7.3.1 LivaNova Company Information
7.3.2 LivaNova Introduction and Business Overview
7.3.3 LivaNova Cell Saver Sales, Revenue and Gross Margin (2019-2024)
7.3.4 LivaNova Cell Saver Product Offerings
7.3.5 LivaNova Recent Development
7.4 BD
7.4.1 BD Company Information
7.4.2 BD Introduction and Business Overview
7.4.3 BD Cell Saver Sales, Revenue and Gross Margin (2019-2024)
7.4.4 BD Cell Saver Product Offerings
7.4.5 BD Recent Development
7.5 Fresenius Kabi
7.5.1 Fresenius Kabi Company Information
7.5.2 Fresenius Kabi Introduction and Business Overview
7.5.3 Fresenius Kabi Cell Saver Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Fresenius Kabi Cell Saver Product Offerings
7.5.5 Fresenius Kabi Recent Development
7.6 Beijing ZKSK Technology
7.6.1 Beijing ZKSK Technology Company Information
7.6.2 Beijing ZKSK Technology Introduction and Business Overview
7.6.3 Beijing ZKSK Technology Cell Saver Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Beijing ZKSK Technology Cell Saver Product Offerings
7.6.5 Beijing ZKSK Technology Recent Development
8 Industry Chain Analysis
8.1 Cell Saver Industrial Chain
8.2 Cell Saver Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cell Saver Sales Model
8.5.2 Sales Channel
8.5.3 Cell Saver Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Cell Saver was estimated to be worth US$ 277 million in 2025 and is projected to reach US$ 351 million, growing at a CAGR of 3.5% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 133
USD 3950.00
(Single User License)
The global Cell Saver market was valued at US$ 277 million in 2025 and is anticipated to reach US$ 351 million by 2032, at a CAGR of 3.5% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 111
USD 2900.00
(Single User License)
The global Cell Saver market size was US$ 268 million in 2024 and is forecast to a readjusted size of US$ 340 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 80
USD 4250.00
(Single User License)
The global Cell Saver market is projected to grow from US$ 268 million in 2024 to US$ 340 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 144
USD 4900.00
(Single User License)
The global market for Cell Saver was valued at US$ 268 million in the year 2024 and is projected to reach a revised size of US$ 340 million by 2031, growing at a CAGR of 3.5% during the forecast period.
Published Date: 2025-01-16
Pages: 79
USD 2900.00
(Single User License)
The global market for Cell Saver was estimated to be worth US$ 268 million in 2024 and is forecast to a readjusted size of US$ 340 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 106
USD 3950.00
(Single User License)
To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.
Published Date: 2024-04-12
Pages: 95
USD 4900.00
(Single User License)
To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.
Published Date: 2024-01-17
Pages: 80
USD 2900.00
(Single User License)
The global market for Cell Saver was estimated to be worth US$ 277 million in 2025 and is projected to reach US$ 351 million, growing at a CAGR of 3.5% from 2026 to 2032.
Published: 2026-06-16
Pages: 133
The global Cell Saver market was valued at US$ 277 million in 2025 and is anticipated to reach US$ 351 million by 2032, at a CAGR of 3.5% from 2026 to 2032.
Published: 2026-04-17
Pages: 111
The global Cell Saver market size was US$ 268 million in 2024 and is forecast to a readjusted size of US$ 340 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 80
The global Cell Saver market is projected to grow from US$ 268 million in 2024 to US$ 340 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 144
The global market for Cell Saver was valued at US$ 268 million in the year 2024 and is projected to reach a revised size of US$ 340 million by 2031, growing at a CAGR of 3.5% during the forecast period.
Published: 2025-01-16
Pages: 79
The global market for Cell Saver was estimated to be worth US$ 268 million in 2024 and is forecast to a readjusted size of US$ 340 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 106
To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.
Published: 2024-04-12
Pages: 95
To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.
Published: 2024-01-17
Pages: 80
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now